20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Science Behind Poly I:C: Mechanism of Action and Immune Activation

Polyinosinic-polycytidylic acid (Poly I:C) is a synthetic compound that plays a pivotal role in understanding and manipulating the immune system. Its primary mode of action is by acting as a surrogate for viral double-stranded RNA (dsRNA), a common molecular pattern associated with viral infections. Poly I:C is recognized by pattern recognition receptors (PRRs) within host cells, most notably Toll-like receptor 3 (TLR3). TLR3 is predominantly located in the endosomal compartments of cells such as dendritic cells, macrophages, and epithelial cells.

Upon binding to TLR3, Poly I:C initiates a signaling cascade that culminates in the activation of transcription factors like NF-κB and IRFs. This activation leads to the production and secretion of key immune mediators, including Type I interferons (IFN-α/β) and pro-inflammatory cytokines such as IL-12, TNF-α, and IL-6. Type I interferons are crucial for establishing an antiviral state in neighboring cells, inhibiting viral replication. IL-12, in particular, is critical for promoting the differentiation of T helper cells into the Th1 lineage, which is essential for cell-mediated immunity and is vital for clearing intracellular pathogens and controlling tumor growth. Researchers looking to study these intricate immune pathways can purchase Poly I:C from reputable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. to ensure the quality and consistency of their experimental results.

Beyond TLR3, Poly I:C has also been shown to engage cytoplasmic PRRs like RIG-I (retinoic acid-inducible gene I) and MDA-5 (melanoma differentiation-associated gene 5), especially at higher concentrations or when delivered into the cytoplasm. This engagement further amplifies the innate immune response, contributing to a more robust and comprehensive activation of immune cells. The ability to purchase Poly I:C for research allows scientists to precisely modulate these pathways, investigate immune memory, and develop novel immunotherapies. NINGBO INNO PHARMCHEM CO.,LTD. provides high-purity Poly I:C, enabling researchers to accurately study its immune-activating properties and its potential applications in drug discovery and development, making it an indispensable tool for advancing our understanding of immunology.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Poly I:C in Human Medicine: Leveraging Interferon Induction for Antiviral Therapies

Next: Enhancing Immune Responses: Poly I:C as a Key Immunomodulator

All Rights Reserved